RxDoctor Payments Data

Justyna Egan

Optometrist · Oak Ridge, NJNPI 1205122959

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,897 of the $7,747 with a category attached, or 76.1%. It is spread thinly across 14 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,019, more than ten times the $282 reported in 2019. Among optometrist clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,747in general payments, 2019–2025

Across 224 payments — averaging $34.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$2K
  • Alcon$1K
  • Sun Pharmaceutical Industries Inc.$1K
  • Bausch & Lomb Americas Inc.$1K
  • Glaukos Corporation$588
  • Sight Sciences, Inc.$434
  • plus $1K from 8 others

What the payments were for

  • Speaking & faculty fees$80010%
  • Travel & lodging$1,04213%
  • Food & beverage$5,89776%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,747 in reported general payments places this provider in the 95th percentile of 1,357 optometrist providers in New Jersey.

See all optometrist providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost14$8,436
CequaCyclosporine11$6,321
Tobramycin-DexamethasoneTobramycin/Dexamethasone36$1,273
Fluorometholone14$1,164
Latanoprost123$1,008
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat56$854
Timolol Maleate58$670
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha23$237
Brimonidine Tartrate15$186

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan$164$8,43614 claims
Sun Pharmaceutical Industries Inc.Cequa$1,257$6,32111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,357 optometrist providers in New Jersey.

Other optometrist in Oak Ridge

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →